Thalys Medical Technology Group Inc.SSE: 603716

Announcement on Cumulative Litigation, Arbitration and Litigation Progress of the Company and Its Subsidiary

· Issued by Thalys Medical Technology Group Inc. via Shanghai Stock Exchange

Filed with SSE · · 8 pages · Chinese

Summary by 6ix AI

The filing reports that there have been numerous new cases since the last disclosure, with significant amounts involved. It highlights the uncertainty regarding the potential negative impact on the company's profits due to ongoing legal proceedings. The company emphasizes its commitment to monitoring these cases and fulfilling its disclosure obligations to investors.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Cumulative Litigation, Arbitration and Litigation Progress of the Company and Its Subsidiary

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Thalys Medical Technology Group Inc. on 6ix

Earlier from Thalys Medical Technology

Later from Thalys Medical Technology

All Thalys Medical Technology news releases